A

AgeneBio

6 employees

AgeneBio is a neuroscience pharmaceutical company developing treatments for diseases that impact memory.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
pharmaceutical development
amnestic Mild Cognitive Impairment
Health Care
neurodegeneration
Alzheimer's dementia

Date founded

2008

Funding rounds raised

Total raised

$3.4M

from 4 investors over 4 rounds

A

AgeneBio raised $3.4M on September 13, 2019

Investors: National Institutes of Health

A

AgeneBio raised undisclosed on October 11, 2018

Investors: National Institute of Neurological Disorders and Stroke (NINDS) and National Institutes of Health

A

AgeneBio raised undisclosed on January 1, 2015

Investors: Sahsen Ventures, LLC

FAQ